Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Pet owners urged stronger warnings and consent around Librela after reported adverse events; board received public comment
Summary
A public commenter told the Veterinary Medical Board that his dog died after receiving Librela and urged the state to require veterinarians to provide written adverse‑reaction information before administering the drug; commenters cited rising adverse‑event counts and urged restrictions or a state ban.
During public comment on Jan. 14 the Veterinary Medical Board received a written submission and live comment urging stronger owner notification and consent for Librela, an injectable monoclonal antibody product for osteoarthritis pain in dogs.
What the public said
Steve Mayo (written comment read into the record) described losing a family dog and said he discovered veterinary medical records after the dog’s death that showed treatment and medication entries he had not been told about. He urged the board to…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
